Journal of Physiology and Biochemistry

, Volume 66, Issue 2, pp 127–136

Systemic antioxidant properties of L-carnitine in two different models of arterial hypertension


    • Departamento de Fisiología y Zoología, Facultad de FarmaciaUniversidad de Sevilla
  • José L. Miguel-Carrasco
    • Departamento de Fisiología y Zoología, Facultad de FarmaciaUniversidad de Sevilla
  • María T. Monserrat
    • Servicio de Medicina InternaHospital Universitario Virgen Macarena
  • Carmen M. Vázquez
    • Departamento de Fisiología y Zoología, Facultad de FarmaciaUniversidad de Sevilla
Original Paper

DOI: 10.1007/s13105-010-0017-7

Cite this article as:
Mate, A., Miguel-Carrasco, J.L., Monserrat, M.T. et al. J Physiol Biochem (2010) 66: 127. doi:10.1007/s13105-010-0017-7


In spite of a wide range of drugs being available in the market, treatment of arterial hypertension still remains a challenge, and new therapeutic strategies could be developed in order to improve the rate of success in controlling this disease. Since oxidative stress has gained importance in the last few years as one of the mechanisms involved in the origin and development of hypertension, and considering that L-carnitine (LC) is a useful compound in different pathologies characterized by increased oxidative status, the aim of the present study was to investigate the systemic antioxidant effect of LC and its correlation to blood pressure in two experimental models of hypertension: (1) spontaneously hypertensive rats (SHR) and (2) rats with hypertension induced by Nω-nitro-L-arginine methyl ester (L-NAME). Treatment with captopril was also performed in SHR in order to compare the antioxidant and antihypertensive effects of LC and captopril. The antioxidant defense capacity, in terms of antioxidant enzyme activity, glutathione system availability and plasma total antioxidant capacity, was measured in both animal models with or without an oral, chronic treatment with LC. All the antioxidant parameters studied were diminished in SHR and in L-NAME-treated animals, an alteration that was in general reversed after treatments with LC and captopril. In addition, LC produced a significant but not complete reduction of systolic and diastolic blood pressure levels in these two models of hypertension, whereas captopril was able to normalize blood pressure. Both LC and captopril prevented the reduction in nitric oxide (NO) levels observed in hypertensive animals. This suggests a decrease in the systemic oxidative stress and a higher availability of NO induced by LC in a similar way to captopril’s effects, which could be relevant in the management of arterial hypertension eventually.


CaptoprilL-carnitineL-NAMENitric oxideOxidative stressSpontaneously hypertensive rats

Copyright information

© University of Navarra 2010